-

Nomi Health Launches Everyday Health Fairs in Hawaii

Company Serves Hundreds of Attendees with Free Healthcare Services including Cholesterol and Blood Pressure Screenings

HONOLULU--(BUSINESS WIRE)--Direct healthcare company Nomi Health hosted its first Everyday Health Fair for free health screenings at Waikele Premium Outlets in Hawaii this weekend. More than 350 people attended the fair, which provided no-cost blood pressure, blood glucose and cholesterol tests, including consultations with Nomi Health’s medical director, June Steely. Nomi Health, the direct healthcare company better known for COVID testing in Hawaii, has nine COVID testing sites on Oahu, the Big Island and Kauai.

Community partners from Project Vision, FilCom Cares, Waipahu Aloha Clubhouse and Pearl City High School Project Grad joined the festivities to offer educational resources and family-friendly games and activities to Central Oahu guests. Project Vision also offered free vision exams.

Nomi Health co-founder and CEO Mark Newman said, “Nomi Health’s Everyday Health Fair is part of our broader mission to deliver quality, every day care services to communities nationwide. We have served major metropolitan markets to rural, difficult-to-reach communities in Utah, Nebraska, Florida, Iowa, Texas, and beyond. Now, as access to care declines and as costs continue to skyrocket in the wake of the pandemic, bringing quality care directly to people is more critical than ever. We are honored to have brought this model of care to Hawaii.”

Over the past year, Nomi Health has provided Americans across the country with everyday healthcare services such as glucose screenings, blood pressure screening, influenza testing and more.

About Nomi Health

Nomi Health is a direct healthcare company focused on making healthcare actually work for those who buy it for their states, organizations, and constituents. We’re a team of over 2,000 – each actively working to connect buyers and healthcare providers directly to lower costs, deliver care solutions to all and rewire the health system to run in real-time. From the front lines of COVID testing and vaccinations, serving over 10 million Americans and more than 40,000 patients each day, to building new ecosystems of buyers such as States and Counties without middlemen, Nomi delivers a solution for our nation’s leaders seeking to widen access to care while lowering cost of care. Visit us @NomiHealth and www.nomihealth.com.

Contacts

Shari Nakakura
mPR, Inc. for Nomi Health
shari@mpublicrelations.com

Nomi Health


Release Summary
Nomi Health launches Everyday Health Fairs in Hawaii serving hundreds of attendees with free healthcare services
Release Versions

Contacts

Shari Nakakura
mPR, Inc. for Nomi Health
shari@mpublicrelations.com

More News From Nomi Health

CerpassRx Launches AI Engine Powered By Waltz Health to Deliver Real-Time Savings and Spend Management for Specialty Drugs

DALLAS & CHICAGO--(BUSINESS WIRE)--CerpassRx, a leader in pharmacy benefit management (PBM), today announced the launch of the Intelligent Specialty Engine, an AI-enabled platform powered by Waltz Health to manage specialty drug spend. CerpassRx’s innovative approach includes real-time analytics and specialty spend management capabilities that drive significant cost savings, improve transparency and optimize the specialty drug experience for health plan customers and their members – or self-ins...

CareSource and Nomi Health Launch Innovative Partnership to Improve Healthcare Access and Outcomes

DAYTON, Ohio--(BUSINESS WIRE)--CareSource, a non-profit health plan with over 2 million members, has selected Nomi Health to partner with it in launching a new comprehensive effort to help close gaps in healthcare access and outcomes for its Medicaid members across Ohio, Georgia, and Indiana. This collaboration aims to enhance access to essential healthcare services and improve overall health outcomes for people facing barriers to care. "This partnership with Nomi Health represents a significan...

Weight Loss Drugs Weigh Heavy on Employer Health Plans

OREM, Utah--(BUSINESS WIRE)--A meteoric rise in the popularity of glucagon-like peptide-1 (GLP-1) medications such as Ozempic, Wegovy and Mounjaro is creating financial challenges for employer-sponsored health plans. New data from Nomi Health, a company changing healthcare economics, reveals that spending on these diabetes and weight loss drugs went up 253% from 2020 to 2023, surpassing $1 billion last year and making up nearly 10% of total prescription costs for employers. Nomi Health analyzed...
Back to Newsroom